PHARMACOLOGIC PRINCIPLES IN POST-TRANSPLANT HYPERTENSION THERAPEUTICS<br>The benefit to risk ratio of antihypertensive medication in the kidney transplant recipient needs to be carefully considered to minimize adverse events. For most drugs and most of the general population, pharmacokinetic considerations are of less importance than they are in the kidney transplant population given the variability of renal function, medical comorbidity, and large medication burden.
การแปล กรุณารอสักครู่..
